Article
Genetic modification of an echinocandin B-producing strain of Aspergillus nidulans to produce mutants blocked in sterigmatocystin biosynthesis.
Journal of industrial microbiology - 1 Nov 1994
Hodges R L, Hodges D W, Goggans K, Xuei X, Skatrud P, McGilvray D
Abstract excerpt
The production of echinocandin B (ECB), a lipopolypeptide used for chemical manufacture of the anti-Candida agent Cilofungin, was accomplished by fermentation using a strain of Aspergillus nidulans. In addition to ECB, this fermentation also produces a significant amount of sterigmatocystin (ST), a potent carcinogen structurally related to the aflatoxins. Mutants blocked in the ST biosynthetic pathway were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
